{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:11:03Z","timestamp":1792069863274,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bacterial vaginosis (BV) is the most common vaginal infection affecting women of childbearing age, and is associated with a substantial burden on women\u2019s physical, emotional, sexual and social lives, as well as being linked to a number of gynaecological and obstetrical complications and adverse pregnancy outcomes. Antibiotics, such as metronidazole or clindamycin, are recommended as first-line treatment for BV, but may be associated with antibiotic resistance, high rates of recurrence and poor patient treatment satisfaction. Astodrimer sodium gel is a novel, non-antibiotic treatment for BV that is not systemically absorbed. It prevents pathogenic bacteria from adhering to the vaginal wall, and disrupts and inhibits the formation of pathogenic bacterial biofilms. Clinical cure rates of 50\u201357% were observed in patients with BV treated with astodrimer sodium compared with 17\u201321% treated with placebo (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) in Phase 3 trials. In a separate Phase 3 trial, recurrence of BV occurred in 44% of patients treated with astodrimer sodium compared with 54% of patients who received placebo (<jats:italic>p<\/jats:italic>\u2009=\u20090.015). Astodrimer sodium is well tolerated, with vulvovaginal candidosis being the only treatment-related adverse event reported to occur more often than with placebo. The availability of astodrimer sodium, a well-tolerated, convenient, non-antibiotic treatment for BV, represents significant progress in the treatment of this burdensome condition.<\/jats:p>","DOI":"10.1007\/s00404-022-06429-z","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T18:02:43Z","timestamp":1646416963000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Astodrimer sodium and bacterial vaginosis: a mini review"],"prefix":"10.1007","volume":"306","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-9411","authenticated-orcid":false,"given":"Werner","family":"Mendling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5497-5063","authenticated-orcid":false,"given":"Wolfgang","family":"Holzgreve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"6429_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1365-2672.2011.04977.x","volume":"110","author":"Y Turovskiy","year":"2011","unstructured":"Turovskiy Y, Sutyak Noll K, Chikindas ML (2011) The aetiology of bacterial vaginosis. J Appl Microbiol 110:1105\u20131128. https:\/\/doi.org\/10.1111\/j.1365-2672.2011.04977.x","journal-title":"J Appl Microbiol"},{"key":"6429_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV (2019) High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 46:304\u2013311. https:\/\/doi.org\/10.1097\/OLQ.0000000000000972","journal-title":"Sex Transm Dis"},{"key":"6429_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074378","volume":"8","author":"JE Bilardi","year":"2013","unstructured":"Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C et al (2013) The burden of bacterial vaginosis: Women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS ONE 8:e74378. https:\/\/doi.org\/10.1371\/journal.pone.0074378","journal-title":"PLoS ONE"},{"key":"6429_CR4","unstructured":"Centers for Disease Control and Prevention. Bacterial Vaginosis 2021 [Available from: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/bv.htm."},{"key":"6429_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.631972","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Lu Y, Chen T, Li R (2021) The female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol 11:631972. https:\/\/doi.org\/10.3389\/fcimb.2021.631972","journal-title":"Front Cell Infect Microbiol"},{"key":"6429_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ajog.2020.10.019","volume":"224","author":"J Ravel","year":"2021","unstructured":"Ravel J, Moreno I, Simon C (2021) Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol 224:251\u2013257. https:\/\/doi.org\/10.1016\/j.ajog.2020.10.019","journal-title":"Am J Obstet Gynecol"},{"key":"6429_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0956462418785451","volume":"29","author":"J Sherrard","year":"2018","unstructured":"Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS (2018) 2018 European (IUSTI\/WHO) international union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS 29:1258\u20131272. https:\/\/doi.org\/10.1177\/0956462418785451","journal-title":"Int J STD AIDS"},{"key":"6429_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1055\/s-0033-1360230","volume":"74","author":"W Mendling","year":"2014","unstructured":"Mendling W, Martius J, Hoyme UB (2014) S1-guideline on bacterial vaginosis in gynecology and obstetrics: long version\u2014AWMF guideline, registration no. 015\/028, July 2013 Langfassung\u2014AWMF-Register Nr. 015\/028, Juli 2013. Geburtshilfe Frauenheilkd 74:51\u201354. https:\/\/doi.org\/10.1055\/s-0033-1360230","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"6429_CR9","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1128\/JCM.43.9.4492-4497.2005","volume":"43","author":"MN Austin","year":"2005","unstructured":"Austin MN, Beigi RH, Meyn LA, Hillier SL (2005) Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 43:4492\u20134497. https:\/\/doi.org\/10.1128\/JCM.43.9.4492-4497.2005","journal-title":"J Clin Microbiol"},{"key":"6429_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ajog.2004.05.033","volume":"191","author":"RH Beigi","year":"2004","unstructured":"Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL (2004) Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191:1124\u20131129. https:\/\/doi.org\/10.1016\/j.ajog.2004.05.033","journal-title":"Am J Obstet Gynecol"},{"key":"6429_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060719","author":"RJ Joseph","year":"2021","unstructured":"Joseph RJ, Ser HL, Kuai YH, Tan LT, Arasoo VJT, Letchumanan V et al (2021) Finding a balance in the vaginal microbiome: how do we treat and prevent the occurrence of bacterial vaginosis? Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics10060719","journal-title":"Antibiotics (Basel)"},{"key":"6429_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151794","volume":"11","author":"J Bilardi","year":"2016","unstructured":"Bilardi J, Walker S, McNair R, Mooney-Somers J, Temple-Smith M, Bellhouse C et al (2016) Women\u2019s management of recurrent bacterial vaginosis and experiences of clinical care: a qualitative study. PLoS ONE 11:e0151794. https:\/\/doi.org\/10.1371\/journal.pone.0151794","journal-title":"PLoS ONE"},{"key":"6429_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4103\/0975-7406.90102","volume":"3","author":"N Kumar","year":"2011","unstructured":"Kumar N, Behera B, Sagiri SS, Pal K, Ray SS, Roy S (2011) Bacterial vaginosis: etiology and modalities of treatment\u2014A brief note. J Pharm Bioallied Sci 3:496\u2013503. https:\/\/doi.org\/10.4103\/0975-7406.90102","journal-title":"J Pharm Bioallied Sci"},{"key":"6429_CR14","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.5897\/ajppx2013.0001","volume":"7","author":"I Truter","year":"2013","unstructured":"Truter I, Graz M (2013) Bacterial vaginosis: literature review of treatment options with specific emphasis on non-antibiotic treatment. Afr J Pharm Pharmacol 7:3060\u20133067. https:\/\/doi.org\/10.5897\/ajppx2013.0001","journal-title":"Afr J Pharm Pharmacol"},{"key":"6429_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16203859","author":"Z Wang","year":"2019","unstructured":"Wang Z, He Y, Zheng Y (2019) Probiotics for the treatment of bacterial vaginosis: a meta-analysis. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph16203859","journal-title":"Int J Environ Res Public Health"},{"key":"6429_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232394","volume":"15","author":"AS Waldbaum","year":"2020","unstructured":"Waldbaum AS, Schwebke JR, Paull JRA, Price CF, Edmondson SR, Castellarnau A et al (2020) A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose-ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis. PLoS ONE 15:e0232394. https:\/\/doi.org\/10.1371\/journal.pone.0232394","journal-title":"PLoS ONE"},{"key":"6429_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejogrb.2019.11.032","volume":"245","author":"SE Chavoustie","year":"2020","unstructured":"Chavoustie SE, Carter BA, Waldbaum AS, Donders GGG, Peters KH, Schwebke JR et al (2020) Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 245:13\u201318. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.11.032","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6429_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurox.2021.100121","volume":"10","author":"JR Schwebke","year":"2021","unstructured":"Schwebke JR, Carter BA, Waldbaum AS, Agnew KJ, Paull JRA, Price CF et al (2021) A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol X 10:100121. https:\/\/doi.org\/10.1016\/j.eurox.2021.100121","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"6429_CR19","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.humic.2018.11.002","volume":"11","author":"K Diop","year":"2019","unstructured":"Diop K, Dufour JC, Levasseur A, Fenollar F (2019) Exhaustive repertoire of human vaginal microbiota. Hum Microbiome J 11:100051","journal-title":"Hum Microbiome J"},{"key":"6429_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1515\/labmed-2016-0011","volume":"40","author":"W Mendling","year":"2016","unstructured":"Mendling W (2016) Normal and abnormal vaginal microbiota. LaboratoriumsMedizin 40:239\u2013246. https:\/\/doi.org\/10.1515\/labmed-2016-0011","journal-title":"LaboratoriumsMedizin"},{"key":"6429_CR21","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/nejmoa043802","volume":"353","author":"DN Fredricks","year":"2005","unstructured":"Fredricks DN, Fiedler TL, Marrazzo JM (2005) Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353:1899\u20131911. https:\/\/doi.org\/10.1056\/nejmoa043802","journal-title":"N Engl J Med"},{"key":"6429_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/1471-2164-11-488","volume":"11","author":"Z Ling","year":"2010","unstructured":"Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y et al (2010) Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genom 11:488. https:\/\/doi.org\/10.1186\/1471-2164-11-488","journal-title":"BMC Genom"},{"key":"6429_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1471-0528.2010.02840.x","volume":"118","author":"RF Lamont","year":"2011","unstructured":"Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP et al (2011) The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 118:533\u2013549. https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02840.x","journal-title":"BJOG"},{"issue":"Suppl 1","key":"6429_CR24","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL et al (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108(Suppl 1):4680\u20134687. https:\/\/doi.org\/10.1073\/pnas.1002611107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6429_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2180-12-83","volume":"12","author":"V Jespers","year":"2012","unstructured":"Jespers V, Menten J, Smet H, Poradosu S, Abdellati S, Verhelst R et al (2012) Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol 12:83. https:\/\/doi.org\/10.1186\/1471-2180-12-83","journal-title":"BMC Microbiol"},{"key":"6429_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054379","volume":"8","author":"T Drell","year":"2013","unstructured":"Drell T, Lillsaar T, Tummeleht L, Simm J, Aaspollu A, Vain E et al (2013) Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women. PLoS ONE 8:e54379. https:\/\/doi.org\/10.1371\/journal.pone.0054379","journal-title":"PLoS ONE"},{"key":"6429_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fmed.2018.00181","volume":"5","author":"E Amabebe","year":"2018","unstructured":"Amabebe E, Anumba DOC (2018) The vaginal microenvironment: the physiologic role of lactobacilli. Front Med (Lausanne) 5:181. https:\/\/doi.org\/10.3389\/fmed.2018.00181","journal-title":"Front Med (Lausanne)"},{"key":"6429_CR28","doi-asserted-by":"publisher","first-page":"8349601","DOI":"10.1155\/2018\/8349601","volume":"2018","author":"E Ranjit","year":"2018","unstructured":"Ranjit E, Raghubanshi BR, Maskey S, Parajuli P (2018) Prevalence of bacterial vaginosis and its association with risk factors among nonpregnant women: a hospital based study. Int J Microbiol 2018:8349601. https:\/\/doi.org\/10.1155\/2018\/8349601","journal-title":"Int J Microbiol"},{"key":"6429_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.14670\/HH-29.10.567","volume":"29","author":"A Swidsinski","year":"2014","unstructured":"Swidsinski A, Loening-Baucke V, Mendling W, Dorffel Y, Schilling J, Halwani Z et al (2014) Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). Histol Histopathol 29:567\u2013587. https:\/\/doi.org\/10.14670\/HH-29.10.567","journal-title":"Histol Histopathol"},{"key":"6429_CR30","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/infdis\/jiz342","volume":"220","author":"CA Muzny","year":"2019","unstructured":"Muzny CA, Taylor CM, Swords WE, Tamhane A, Chattopadhyay D, Cerca N et al (2019) An updated conceptual model on the pathogenesis of bacterial vaginosis. J Infect Dis 220:1399\u20131405. https:\/\/doi.org\/10.1093\/infdis\/jiz342","journal-title":"J Infect Dis"},{"key":"6429_CR31","first-page":"967","volume":"6","author":"BG Udayalaxmi","year":"2012","unstructured":"Udayalaxmi BG, Kotigadde S, Kotian S (2012) Effect of pH on the adherence, surface hydrophobicity and the biofilm formation of Gardnerella vaginalis. J Clin Diag Res 6:967\u2013969","journal-title":"J Clin Diag Res"},{"key":"6429_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:14\u201322. https:\/\/doi.org\/10.1016\/0002-9343(83)91112-9","journal-title":"Am J Med"},{"key":"6429_CR33","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1001\/archinte.1990.00390200111021","volume":"150","author":"VM Schaaf","year":"1990","unstructured":"Schaaf VM, Perez-Stable EJ, Borchardt K (1990) The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 150:1929\u20131933","journal-title":"Arch Intern Med"},{"key":"6429_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.AOG.0000134783.98382.b0","volume":"104","author":"MA Klebanoff","year":"2004","unstructured":"Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW (2004) Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 104:267\u2013272. https:\/\/doi.org\/10.1097\/01.AOG.0000134783.98382.b0","journal-title":"Obstet Gynecol"},{"key":"6429_CR35","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1093\/geronb\/gbu105","volume":"69","author":"JN Hoffmann","year":"2014","unstructured":"Hoffmann JN, You HM, Hedberg EC, Jordan JA, McClintock MK (2014) Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci Soc Sci 69:S205\u2013S214. https:\/\/doi.org\/10.1093\/geronb\/gbu105","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"6429_CR36","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jama.291.11.1368","volume":"291","author":"MR Anderson","year":"2004","unstructured":"Anderson MR, Klink K, Cohrssen A (2004) Evaluation of vaginal complaints. JAMA 291:1368\u20131379. https:\/\/doi.org\/10.1001\/jama.291.11.1368","journal-title":"JAMA"},{"key":"6429_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297\u2013301. https:\/\/doi.org\/10.1128\/jcm.29.2.297-301.1991","journal-title":"J Clin Microbiol"},{"key":"6429_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/infdis\/160.3.490","volume":"160","author":"RL Cook","year":"1989","unstructured":"Cook RL, Reid G, Pond DG, Schmitt CA, Sobel JD (1989) Clue cells in bacterial vaginosis: immunofluorescent identification of the adherent gram-negative bacteria as Gardnerella vaginalis. J Infect Dis 160:490\u2013496. https:\/\/doi.org\/10.1093\/infdis\/160.3.490","journal-title":"J Infect Dis"},{"key":"6429_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1086\/592974","volume":"47","author":"KA Fethers","year":"2008","unstructured":"Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS (2008) Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis 47:1426\u20131435. https:\/\/doi.org\/10.1086\/592974","journal-title":"Clin Infect Dis"},{"key":"6429_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141905","volume":"10","author":"DS Forcey","year":"2015","unstructured":"Forcey DS, Vodstrcil LA, Hocking JS, Fairley CK, Law M, McNair RP et al (2015) Factors associated with bacterial vaginosis among women who have sex with women: a systematic review. PLoS ONE 10:e0141905. https:\/\/doi.org\/10.1371\/journal.pone.0141905","journal-title":"PLoS ONE"},{"key":"6429_CR41","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/648092","volume":"200","author":"KA Fethers","year":"2009","unstructured":"Fethers KA, Fairley CK, Morton A, Hocking JS, Hopkins C, Kennedy LJ et al (2009) Early sexual experiences and risk factors for bacterial vaginosis. J Infect Dis 200:1662\u20131670. https:\/\/doi.org\/10.1086\/648092","journal-title":"J Infect Dis"},{"key":"6429_CR42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/OLQ.0000000000000004","volume":"40","author":"CA Muzny","year":"2013","unstructured":"Muzny CA, Sunesara IR, Austin EL, Mena LA, Schwebke JR (2013) Bacterial vaginosis among African American women who have sex with women. Sex Transm Dis 40:751\u2013755. https:\/\/doi.org\/10.1097\/OLQ.0000000000000004","journal-title":"Sex Transm Dis"},{"key":"6429_CR43","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","volume":"34","author":"EH Koumans","year":"2007","unstructured":"Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M et al (2007) The prevalence of bacterial vaginosis in the United States, 2001\u20132004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34:864\u2013869. https:\/\/doi.org\/10.1097\/OLQ.0b013e318074e565","journal-title":"Sex Transm Dis"},{"key":"6429_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/sti.77.1.63","volume":"77","author":"MC Morris","year":"2001","unstructured":"Morris MC, Rogers PA, Kinghorn GR (2001) Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect 77:63\u201368. https:\/\/doi.org\/10.1136\/sti.77.1.63","journal-title":"Sex Transm Infect"},{"key":"6429_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/1471-2334-13-208","volume":"13","author":"FA Guedou","year":"2013","unstructured":"Guedou FA, Van Damme L, Deese J, Crucitti T, Becker M, Mirembe F et al (2013) Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial. BMC Infect Dis 13:208. https:\/\/doi.org\/10.1186\/1471-2334-13-208","journal-title":"BMC Infect Dis"},{"key":"6429_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/infdis\/167.3.783","volume":"167","author":"JD Sobel","year":"1993","unstructured":"Sobel JD, Schmitt C, Meriwether C (1993) Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis 167:783\u2013784. https:\/\/doi.org\/10.1093\/infdis\/167.3.783","journal-title":"J Infect Dis"},{"key":"6429_CR47","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM et al (2006) High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193:1478\u20131486. https:\/\/doi.org\/10.1086\/503780","journal-title":"J Infect Dis"},{"key":"6429_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00227-19","author":"JD Sobel","year":"2019","unstructured":"Sobel JD, Kaur N, Woznicki NA, Boikov D, Aguin T, Gill G et al (2019) Prognostic indicators of recurrence of bacterial vaginosis. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.00227-19","journal-title":"J Clin Microbiol"},{"key":"6429_CR49","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1038\/s41467-020-19880-w","volume":"11","author":"CY Lee","year":"2020","unstructured":"Lee CY, Cheu RK, Lemke MM, Gustin AT, France MT, Hampel B et al (2020) Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis. Nat Commun 11:6147. https:\/\/doi.org\/10.1038\/s41467-020-19880-w","journal-title":"Nat Commun"},{"key":"6429_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256445","volume":"16","author":"E Turner","year":"2021","unstructured":"Turner E, Sobel JD, Akins RA (2021) Prognosis of recurrent bacterial vaginosis based on longitudinal changes in abundance of Lactobacillus and specific species of Gardnerella. PLoS ONE 16:e0256445. https:\/\/doi.org\/10.1371\/journal.pone.0256445","journal-title":"PLoS ONE"},{"key":"6429_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mob.2003.339","volume":"189","author":"H Leitich","year":"2003","unstructured":"Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P (2003) Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 189:139\u2013147. https:\/\/doi.org\/10.1067\/mob.2003.339","journal-title":"Am J Obstet Gynecol"},{"key":"6429_CR52","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1471-0528.2006.01087.x","volume":"113","author":"JA Svare","year":"2006","unstructured":"Svare JA, Schmidt H, Hansen BB, Lose G (2006) Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG 113:1419\u20131425. https:\/\/doi.org\/10.1111\/j.1471-0528.2006.01087.x","journal-title":"BJOG"},{"key":"6429_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bpobgyn.2006.12.005","volume":"21","author":"H Leitich","year":"2007","unstructured":"Leitich H, Kiss H (2007) Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 21:375\u2013390. https:\/\/doi.org\/10.1016\/j.bpobgyn.2006.12.005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"6429_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/AOG.0b013e3181c391d7","volume":"115","author":"JP Menard","year":"2010","unstructured":"Menard JP, Mazouni C, Salem-Cherif I, Fenollar F, Raoult D, Boubli L et al (2010) High vaginal concentrations of Atopobium vaginae and Gardnerella vaginalis in women undergoing preterm labor. Obstet Gynecol 115:134\u2013140. https:\/\/doi.org\/10.1097\/AOG.0b013e3181c391d7","journal-title":"Obstet Gynecol"},{"key":"6429_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.567885","volume":"8","author":"NCA Juliana","year":"2020","unstructured":"Juliana NCA, Suiters MJM, Al-Nasiry S, Morre SA, Peters RPH, Ambrosino E (2020) The association between vaginal microbiota dysbiosis, bacterial vaginosis, and aerobic vaginitis, and adverse pregnancy outcomes of women living in sub-saharan africa: a systematic review. Front Public Health 8:567885. https:\/\/doi.org\/10.3389\/fpubh.2020.567885","journal-title":"Front Public Health"},{"key":"6429_CR56","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/humrep\/det096","volume":"28","author":"N van Oostrum","year":"2013","unstructured":"van Oostrum N, De Sutter P, Meys J, Verstraelen H (2013) Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod 28:1809\u20131815. https:\/\/doi.org\/10.1093\/humrep\/det096","journal-title":"Hum Reprod"},{"key":"6429_CR57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/1471-0528.15178","volume":"126","author":"T Haahr","year":"2019","unstructured":"Haahr T, Zacho J, Brauner M, Shathmigha K, Skov Jensen J, Humaidan P (2019) Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. BJOG 126:200\u2013207. https:\/\/doi.org\/10.1111\/1471-0528.15178","journal-title":"BJOG"},{"key":"6429_CR58","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/s0029-7844(02)02118-x","volume":"100","author":"HC Wiesenfeld","year":"2002","unstructured":"Wiesenfeld HC, Hillier SL, Krohn MA, Amortegui AJ, Heine RP, Landers DV et al (2002) Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 100:456\u2013463. https:\/\/doi.org\/10.1016\/s0029-7844(02)02118-x","journal-title":"Obstet Gynecol"},{"key":"6429_CR59","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00404-020-05675-3","volume":"302","author":"X Hong","year":"2020","unstructured":"Hong X, Ma J, Yin J, Fang S, Geng J, Zhao H et al (2020) The association between vaginal microbiota and female infertility: a systematic review and meta-analysis. Arch Gynecol Obstet 302:569\u2013578. https:\/\/doi.org\/10.1007\/s00404-020-05675-3","journal-title":"Arch Gynecol Obstet"},{"key":"6429_CR60","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","volume":"22","author":"J Atashili","year":"2008","unstructured":"Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22:1493\u20131501. https:\/\/doi.org\/10.1097\/QAD.0b013e3283021a37","journal-title":"AIDS"},{"key":"6429_CR61","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.amepre.2016.09.016","volume":"52","author":"CT Bautista","year":"2017","unstructured":"Bautista CT, Wurapa EK, Sateren WB, Morris SM, Hollingsworth BP, Sanchez JL (2017) Association of bacterial vaginosis with chlamydia and gonorrhea among women in the U.S. Army Am J Prev Med 52:632\u2013639. https:\/\/doi.org\/10.1016\/j.amepre.2016.09.016","journal-title":"Army Am J Prev Med"},{"issue":"113","key":"6429_CR62","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.ajog.2011.02.060","volume":"205","author":"JE Allsworth","year":"2011","unstructured":"Allsworth JE, Peipert JF (2011) Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol 205(113):e111-116. https:\/\/doi.org\/10.1016\/j.ajog.2011.02.060","journal-title":"Am J Obstet Gynecol"},{"key":"6429_CR63","first-page":"561","volume":"2","author":"R Rupp","year":"2007","unstructured":"Rupp R, Rosenthal SL, Stanberry LR (2007) VivaGel (SPL7013 Gel): a candidate dendrimer\u2013microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine 2:561\u2013566","journal-title":"Int J Nanomedicine"},{"key":"6429_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012309","volume":"5","author":"D Tyssen","year":"2010","unstructured":"Tyssen D, Henderson SA, Johnson A, Sterjovski J, Moore K, La J et al (2010) Structure activity relationship of dendrimer microbicides with dual action antiviral activity. PLoS ONE 5:e12309. https:\/\/doi.org\/10.1371\/journal.pone.0012309","journal-title":"PLoS ONE"},{"key":"6429_CR65","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1128\/AAC.47.12.3784-3788.2003","volume":"47","author":"DI Bernstein","year":"2003","unstructured":"Bernstein DI, Stanberry LR, Sacks S, Ayisi NK, Gong YH, Ireland J et al (2003) Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother 47:3784\u20133788. https:\/\/doi.org\/10.1128\/AAC.47.12.3784-3788.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"6429_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.antiviral.2005.08.004","volume":"68","author":"E Gong","year":"2005","unstructured":"Gong E, Matthews B, McCarthy T, Chu J, Holan G, Raff J et al (2005) Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antiviral Res 68:139\u2013146. https:\/\/doi.org\/10.1016\/j.antiviral.2005.08.004","journal-title":"Antiviral Res"},{"key":"6429_CR67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/aid.2005.21.207","volume":"21","author":"YH Jiang","year":"2005","unstructured":"Jiang YH, Emau P, Cairns JS, Flanary L, Morton WR, McCarthy TD et al (2005) SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. AIDS Res Hum Retroviruses 21:207\u2013213. https:\/\/doi.org\/10.1089\/aid.2005.21.207","journal-title":"AIDS Res Hum Retroviruses"},{"key":"6429_CR68","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1128\/AAC.50.5.1696-1700.2006","volume":"50","author":"DL Patton","year":"2006","unstructured":"Patton DL, Cosgrove Sweeney YT, McCarthy TD, Hillier SL (2006) Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother 50:1696\u20131700. https:\/\/doi.org\/10.1128\/AAC.50.5.1696-1700.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"6429_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14165","volume":"75","author":"A Abu-Zaid","year":"2021","unstructured":"Abu-Zaid A, Alshahrani MS, Bakhsh H, Miski NT, Abuzaid M, Alomar O et al (2021) Astodrimer gel for treatment of bacterial vaginosis: A systematic review and meta-analysis of randomized controlled trials. Int J Clin Pract 75:e14165. https:\/\/doi.org\/10.1111\/ijcp.14165","journal-title":"Int J Clin Pract"},{"key":"6429_CR70","unstructured":"Mundipharma Medical GmbH (2020) BETAFEM\u00ae BV Gel, instructions for use"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06429-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:24:08Z","timestamp":1658309048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06429-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6429"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06429-z","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WM and WH are Members of the scientific advisory board of Mundipharma Medical GmbH, Basel, Switzerland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All referenced studies should have obtained the appropriate ethics approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}